1. Home
  2. JWEL vs LYRA Comparison

JWEL vs LYRA Comparison

Compare JWEL & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

HOLD

Current Price

$2.13

Market Cap

5.1M

ML Signal

HOLD

Logo Lyra Therapeutics Inc.

LYRA

Lyra Therapeutics Inc.

HOLD

Current Price

$1.71

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JWEL
LYRA
Founded
2012
2005
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
JWEL
LYRA
Price
$2.13
$1.71
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
31.1K
129.9K
Earning Date
05-12-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$123,450,865.00
$600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$1.63
52 Week High
$3.24
$37.50

Technical Indicators

Market Signals
Indicator
JWEL
LYRA
Relative Strength Index (RSI) 43.40 28.60
Support Level $2.06 $1.63
Resistance Level $2.23 $2.58
Average True Range (ATR) 0.11 0.30
MACD -0.00 -0.05
Stochastic Oscillator 28.21 3.90

Price Performance

Historical Comparison
JWEL
LYRA

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: